Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Intriguing Strange Cruising Objections you Should Visit - 2Czech Republic's new premier: No money for Ukraine
- 3IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin
- 4The Response Uncovered: Disentangling the Secrets of the Universe
- 5Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- Striking American and European television Projects: A Survey
- An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- 'Here we go again': Businesses grapple with fuel costs
- Flu season is ramping up, and some experts are "pretty worried"
- Extreme Manual for Purchasing Your Next Truck
- There are thousands of aligned holes in Peru. Archaeologists now think they know who made them
- The Secret Side of Italy: 12 Underrated Destinations Locals Don’t Want Tourists to Find
- 6 Agreeable Earphones To Wear
- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
